| Investigating Cognitive Impairment in Young Patients With Cancer Prospectively (NCT05840575) | Rigshospitalet, Denmark | 2022-03-01 |
| Twenty Years' Experience in Retroperitoneal Lymph Node Dissection for Testicular Cancer in a Tertiary Referral Center (NCT06806917) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-12-01 |
| Determining the Clinical Relevance of the inTeraction Between AprepitaNt aNd EtoposiDe (NCT04935255) | Radboud University Medical Center | 2021-08-11 |
| The Impact of the COVID-19 Pandemic on Testicular Cancer (NCT05083143) | Ankara Training and Research Hospital | 2021-07-01 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants (NCT05097820) | University Hospital, Ghent | 2021-02-05 |
| Young Adult Latino Testicular Cancer Survivors: a Pilot Study of Goal-Focused Emotion Regulation Therapy (GET) (NCT07615998) | University of California, Irvine | 2020-08-05 |
| Endocrine Disrupting Chemical Exposure and Testicular Cancer (NCT04848545) | Rigshospitalet, Denmark | 2020-06-01 |
| Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy (NCT04180033) | The Netherlands Cancer Institute | 2020-02-18 |
| The Effect of the Brochure on Testicular Self-Exam (NCT05073198) | Selcuk University | 2019-12-05 |
| Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma (NCT03937843) | Swiss Cancer Institute | 2019-07-29 |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) (NCT03896958) | SpeciCare | 2019-03-21 |
| Senescence and the Early Ageing Phenotype After Chemotherapy for Testicular Cancer: the SEA-CAT Study (NCT04113122) | University Medical Center Groningen | 2019-02-09 |
| Short-term Testosterone Replacement in Testicular Cancer Survivors (NCT03339635) | University Medical Center Groningen | 2018-12-21 |
| Role of Axumin PET Scan in Germ Cell Tumor (NCT03426865) | University of Texas Southwestern Medical Center | 2018-03-01 |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry (NCT03452774) | Massive Bio, Inc. | 2018-01-01 |
| WATChmAN Virtual Testicular Cancer Clinic (NCT03360994) | University Health Network, Toronto | 2017-12-15 |
| Development of Diagnostics and Treatment of Urological Cancers (NCT02994758) | Helsinki University Central Hospital | 2017-11-27 |
| Intermediate and Long Term Vascular Effects of Cisplatin in Patients With Testicular Cancer (NCT03557164) | NHS Greater Glasgow and Clyde | 2017-03-01 |
| A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers (NCT02643303) | Ludwig Institute for Cancer Research | 2016-12-28 |
| Study of Testosterone vs Placebo in Testicular Cancer Survivors (NCT02991209) | Mikkel Bandak | 2016-11-01 |
| Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer (NCT02860819) | National Cancer Institute, Slovakia | 2016-08-01 |
| Early Life Exposures in Agriculture (NCT02743481) | National Cancer Institute (NCI) | 2016-04-14 |
| Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors (NCT02689219) | Nabil Adra | 2016-03-09 |
| Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study (NCT02602041) | University Medical Center Groningen | 2015-11-01 |
| Vascular Fingerprint Validation Study (NCT02573584) | University Medical Center Groningen | 2015-10-01 |
| Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study) (NCT02572934) | University Medical Center Groningen | 2015-08-01 |
| Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer (NCT02478502) | University Hospital, Akershus | 2015-06-01 |
| Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors (NCT02429466) | Nasser Hanna | 2015-04-27 |
| TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects (NCT02276430) | University Medical Center Groningen | 2014-07-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| REtrospective Study of TESTIcular CAncer Patients at the University Magdeburg (NCT02092740) | University of Magdeburg | 2012-11-01 |
| Shared Care Follow-up After Chemotherapy for Testicular Cancer (NCT01783145) | University Medical Center Groningen | 2012-10-01 |
| Taste, Smell and Chemotherapy (TASTY) (NCT01641172) | University Medical Center Groningen | 2012-06-01 |
| Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging (NCT01482741) | Memorial Sloan Kettering Cancer Center | 2011-11-01 |
| Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies (NCT01242072) | Alaunos Therapeutics | 2010-11-01 |
| Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer (NCT01242631) | Hannover Medical School | 2010-11-01 |
| Study on the Quality of Life and Functional/Oncological Outcome of Testicular Cancer Patients (NCT06389409) | IRCCS San Raffaele | 2010-08-24 |
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors (NCT00936936) | M.D. Anderson Cancer Center | 2009-06-02 |
| B-Receptor Signaling in Cardiomyopathy (NCT01135849) | Daniel Bernstein | 2008-11-01 |
| Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients (NCT00705094) | AHS Cancer Control Alberta | 2008-09-01 |
| Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy (NCT00772694) | Fondation Wygrajmy Zdrowie | 2008-09-01 |
| Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer (NCT00531687) | Rigshospitalet, Denmark | 2007-09-01 |
| Low-Dose CT - Stage I Testicular Cancer (NCT03142802) | University Health Network, Toronto | 2005-09-16 |
| Relationship of Ochratoxin A to Upper Urologic Cancers (NCT00216801) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2005-09-01 |
| Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk (NCT00820287) | Centre Hospitalier Universitaire de Nice | 2005-09-01 |
| Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma (NCT00183820) | University of Southern California | 2004-11-01 |
| Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases (NCT00587964) | Memorial Sloan Kettering Cancer Center | 2004-06-01 |
| Genetics of Familial Testicular Cancer (NCT00342537) | National Cancer Institute (NCI) | 2004-01-02 |
| Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor (NCT01684098) | Endocyte | 2003-08-01 |
| Cause of Familial Testicular Cancer (NCT00034424) | National Cancer Institute (NCI) | 2003-01-13 |
| A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen (NCT00341588) | National Cancer Institute (NCI) | 2002-01-18 |